Kalbhen D A, Smalla H D
Arzneimittelforschung. 1977;27(5):1050-7.
In the present study we investigated the antiinflammatory effect of pentosanpolysulfate (SP 54) in combination with metamizol using different forms of rat paw edema (induced by dextrane, hyaluronidase, trypsin, formaldehyde, carragenine or kaolin). After s. c. application Probaphen, a new drug containing pentosanpolysulfate, metamizol, and lidocaine, proved in our experiments to exert an antiphlogistic effect about 40% stronger than the equivalent amount of SP 54 alone. Since pentosanpolysulfate by itself has no analgetic activity, its combination with metamizol results in a formulation which is not only a more potent antiinflammatory drug but will aslo counteract pains which accompany most edematous reactions. Probaphen may therefore be suggested for the treatment of rheumatoid arthritis and similar inflammatory and edematous processes. First clinical studies and reports on Probaphen fully support our pharmacological results.
在本研究中,我们使用不同形式的大鼠爪肿胀(由右旋糖酐、透明质酸酶、胰蛋白酶、甲醛、角叉菜胶或高岭土诱导),研究了戊聚糖多硫酸酯(SP 54)与安乃近联合使用的抗炎作用。皮下注射Probaphen(一种含有戊聚糖多硫酸酯、安乃近和利多卡因的新药)后,我们的实验证明,其抗炎作用比等量的单独使用的SP 54强约40%。由于戊聚糖多硫酸酯本身没有镇痛活性,它与安乃近的组合产生了一种制剂,该制剂不仅是一种更有效的抗炎药物,还能抵消大多数水肿反应伴随的疼痛。因此,Probaphen可用于治疗类风湿性关节炎及类似的炎症和水肿过程。关于Probaphen的首批临床研究和报告充分支持了我们的药理学结果。